Investigation on the in vitro cytocompatibility of Mg-Zn-Y-Nd-Zr alloys as degradable orthopaedic implant materials

Biocompatibility Studies Original Research
  • 105 Downloads
Part of the following topical collections:
  1. Biocompatibility Studies

Abstract

Mg-Zn-Y-Nd-Zr alloy has been developed as a new type of biodegradable orthopaedic implant material by the authors’ research group with its excellent mechanical properties and controllable degradation rate. In this study, the cytocompatibility of Mg-Zn-Y-Nd-Zr alloy was systematically evaluated through in vitro cell culture method. MTT assay was applied to evaluate the cytotoxicity of Mg-Zn-Y-Nd-Zr alloy and no toxic effect was observed on L929 and MC3T3-E1 cells followed the protocol of ISO 10993 standard. Considering the potential ion accumulation in the bony environment, this study further investigated the cytotoxic effect of accumulated metallic ions during the alloy degradation by extending the extract preparation time. When the extract preparation time was prolonged to 1440 h, the accumulated metallic ions leaded to severe cell apoptosis, of which the combined ion concentration was determined as 39.5–65.8 µM of Mg2+, 3.5–5.9 µM of Zn2+, 0.44–0.74 µM of Y3+, 0.3–0.52 µM of Nd3+ and 0.11–0.18 µM of Zr4+ for L929, and 65.8–92.2 µM of Mg2+, 5.9–8.3 µM of Zn2+, 0.74–1.04 µM of Y3+, 0.52–0.73 µM of Nd3+ and 0.18–0.25 µM of Zr4+ for MC3T3-E1 cells. Besides the cell viability assessment, high expression of ALP activity and calcified nodules implied that metal elements in Mg-Zn-Y-Nd-Zr alloys can promote the osteogenic differentiation. Hence, excellent cytocompatibility has equipped Mg-Zn-Y-Nd-Zr alloy as a promising candidate for orthopaedic implant application, which can remarkably guide the magnesium-based alloy design and provide scientific evidence for clinical practice in future.

Notes

Acknowledgements

SKG and XZS are supported by the National High-tech Research and Development Projects (863) (Grant No.2015AA033603; No.2015AA020301), National Key Research and Development Program of China (Grant No. 2016YFC1102403) and the Major Science and Technology Projects in Henan Province (141100310900). LC is supported by National Natural Science Foundation of China (Grant No. 51601169).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Staiger MP, Pietak AM, Huadmai J, et al. Magnesium and its alloys as orthopedic biomaterials: A review. Biomaterials. 2006;27:1728–34.CrossRefGoogle Scholar
  2. 2.
    Zheng YF, Gu XN, Witte F. Biodegradable metals. Mater Sci Eng R. 2014;77:1–34.CrossRefGoogle Scholar
  3. 3.
    Saha P, Roy M, Datta MK, et al. Effects of grain refinement on the biocorrosion and in vitro bioactivity of magnesium. Mater Sci & Eng C. 2015;57:294–303.CrossRefGoogle Scholar
  4. 4.
    TSNS Narayanan, Park, Min IS, Strategies HL. to improve the corrosion resistance of microarc oxidation (MAO) coated magnesium alloys for degradable implants: prospects and challenges. Prog Mater Sci. 2014;60:1–71.CrossRefGoogle Scholar
  5. 5.
    Rosalbino F, De NS, Scavino G, et al. Microstructure and in vitro degradation performance of Mg-Zn-Mn alloys for biomedical application. J Biomed Mater Res A. 2013;101:704–11.CrossRefGoogle Scholar
  6. 6.
    Tie D, Guan R, Liu H, et al. An in vivo study on the metabolism and osteogenic activity of bioabsorbable Mg-1Sr alloy. Acta Biomater. 2015;29:455–67.CrossRefGoogle Scholar
  7. 7.
    Chou DT, Hong D, Saha P, et al. In vitro and in vivo corrosion, cytocompatibility and mechanical properties of biodegradable Mg-Y-Ca-Zr alloys as implant materials. Acta Biomater. 2013;9:8518–33.CrossRefGoogle Scholar
  8. 8.
    Sansone V, Pagani D, Melato M. The effects on bone cells of metal ions released from orthopaedic implants. A review. Clin Cases Mineral Bone Metabolism. 2013;10:34–40.Google Scholar
  9. 9.
    Wang B, Guan S, Wang J, et al. Effects of Nd on microstructures and properties of extruded Mg–2Zn–0.46Y– x Nd alloys for stent application. Mater Sci Eng B. 2011;176:1673–8.CrossRefGoogle Scholar
  10. 10.
    Willbold E, Gu X, Albert D, et al. Effect of the addition of low rare earth elements (lanthanum, neodymium, cerium) on the biodegradation and biocompatibility of magnesium. Acta Biomater. 2015;11:554–62.CrossRefGoogle Scholar
  11. 11.
    Zhang JC, Liu CL, Li YP, et al. Effect of yttrium ion on the proliferation, differentiation and mineralization function of primary mouse osteoblasts in vitro. J Rare Earths. 2010;28:466–70.CrossRefGoogle Scholar
  12. 12.
    Salem R, Hunter RD. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma: a review. Int J Radiat Oncol Biol Phys. 2006;127:S194–205.Google Scholar
  13. 13.
    Kokubo T, Takadama H. How useful is SBF in predicting in vivo bone bioactivity? Biomaterials. 2006;27:2907–15.CrossRefGoogle Scholar
  14. 14.
    ISO 10993-12: biological evaluation of medical devices: Sample preparation and reference materials. International Organization for Standardization. 2004; 1–8.Google Scholar
  15. 15.
    ISO 10993-5: biological evaluation of medical devices: Tests for in vitro cytotoxicity. International Organization for Standards. 2009; 1–11.Google Scholar
  16. 16.
    Zhai YK, Pan YL, Niu YB, et al. The importance of the prenyl group in the activities of osthole in enhancing bone formation and inhibiting bone resorption in vitro. Int J Endocrinol. 2014;9:921–54.Google Scholar
  17. 17.
    Alvarez-Lopez M, Pereda MD, Valle JAD, et al. Corrosion behaviour of AZ31 magnesium alloy with different grain sizes in simulated biological fluids. Acta Biomater. 2010;6:1763–71.CrossRefGoogle Scholar
  18. 18.
    Beck GR. Inorganic phosphate as a signaling molecule in osteoblast differentiation. J Cell Biochem. 2003;90:234–43.CrossRefGoogle Scholar
  19. 19.
    Wang J, Witte F, Xi T, et al. Recommendation for modifying current cytotoxicity testing standards for biodegradable magnesium-based materials. Acta Biomater. 2015;21:237–49.CrossRefGoogle Scholar
  20. 20.
    Cutaia M, Black AD, Cohen I, et al. Alkaline stress-induced apoptosis in human pulmonary artery endothelial cells. Apoptosis. 2005;10:1457–67.CrossRefGoogle Scholar
  21. 21.
    Feyerabend F, Fischer J, Holtz J, et al. Evaluation of short-term effects of rare earth and other elements used in magnesium alloys on primary cells and cell lines. Acta Biomater. 2010;6:1834–42.CrossRefGoogle Scholar
  22. 22.
    Myrissa A, Braeuer S, Martinelli E, et al. Gadolinium accumulation in organs of Sprague-Dawley (®) rats after implantation of a biodegradable magnesium-gadolinium alloy. Acta Biomater. 2017;48:521–9.CrossRefGoogle Scholar
  23. 23.
    Liu Y, Chen Z, Wang Y. Distribution and accumulation of neodymium in body of mice and effect on progesterone secretion. J Chinese Rare Earth Soc. 2001;19:447–9.Google Scholar
  24. 24.
    Rim KT, Koo KH, Park JS. Toxicological evaluations of rare earths and their health impacts to workers: a literature review. Saf Health Work. 2013;4:12–26.CrossRefGoogle Scholar
  25. 25.
    Okuma T. Magnesium and bone strength. Nutrition. 2001;17:679–80.CrossRefGoogle Scholar
  26. 26.
    Gao JH, Shi XY, Yang B, et al. Fabrication and characterization of bioactive composite coatings on Mg-Zn-Ca alloy by MAO/sol-gel. J Mater Sci: Mater Med. 2011;22:1681–7.Google Scholar
  27. 27.
    Han P, Cheng P, Zhang S, et al. In vitro and in vivo studies on the degradation of high-purity Mg (99.99wt.%) screw with femoral intracondylar fractured rabbit model. Biomaterials. 2015;64:57–69.CrossRefGoogle Scholar
  28. 28.
    Ikeuchi M, Ito A, Dohi Y, et al. Osteogenic differentiation of cultured rat and human bone marrow cells on the surface of zinc-releasing calcium phosphate ceramics. J Biomed Mater Res A. 2003;67:1115–22.CrossRefGoogle Scholar
  29. 29.
    Ito A, Ojima K, Naito H, et al. Preparation, solubility, and cytocompatibility of zinc‐releasing calcium phosphate ceramics. J Biomed Mater Res A. 2000;50:178–83.CrossRefGoogle Scholar
  30. 30.
    Depprich R, Ommerborn M, Zipprich H, et al. Behavior of osteoblastic cells cultured on titanium and structured zirconia surfaces. Head Face Med. 2008;4:29–39.CrossRefGoogle Scholar
  31. 31.
    Lee DB, Roberts M, Bluchel CG, et al. Zirconium: biomedical and nephrological applications. Asaio Journal. 2010;56:550–6.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.School of Materials Science and EngineeringZhengzhou UniversityZhengzhouChina
  2. 2.Orthopaedic Institute of Henan ProvinceLuoyangChina

Personalised recommendations